Massachusetts-based resuscitation devices maker ZOLL Medical (ZOLL) reported that its AutoPulse cardiac support pumps has been purchased by Kijlstra Ambulance BV, the largest ambulance service in the Netherlands’ Friesland province. The Dutch entity has bought 22 such devices to equip its entire fleet of ambulances. Kijlstra has been using the non-invasive AutoPulse pumps on a couple of its rapid responder vehicles.
The AutoPulse pumps, an automated, portable device offer emergency service providers an effective method of performing consistent, uninterrupted chest compressions on the victims of sudden cardiac arrest (“SCA”) thereby, improving their chances of survival. The device represents an advancement over manual chest compressions as it improves blood flow to the heart and brain during SCA.
SCA, an abrupt loss of cardiac function, is one of the major causes of unexpected deaths claiming more than 1 million lives annually worldwide. According to the American Heart Association, more than 700 people die from this condition each day in the U.S. Improved resuscitation may save as many as 50% of SCA victims.
ZOLL Medical’s AutoPulse business delivered strong growth in the most recent quarter with sales cruising 31% year over year. Nearly 6,000 AutoPulse devices have been used in hospitals and emergency service organizations globally.
ZOLL Medical develops and markets non-invasive resuscitation devices and related software solutions both in the U.S. and overseas markets. It is a leading player in the global market for external defibrillators, which is worth more than $1 billion. To boost growth, ZOLL Medical is expanding its footprint in the international markets, which contribute more than 25% of its annual sales.
ZOLL Medical is the innovator of a wide range of product features that have become the standard of care in the external defibrillator industry. It remains committed to expanding its product range to sustain growth in this market. ZOLL Medical competes with Physio-Control, a wholly-owned unit of Medtronic (MDT) and Philips (PHG). We currently have a Neutral recommendation on the stock.
MEDTRONIC (MDT): Free Stock Analysis Report
KONINKLIJKE PHL (PHG): Free Stock Analysis Report
ZOLL MEDICAL CO (ZOLL): Free Stock Analysis Report
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment